Evidence map›Paper›PMID 32994900›Full record

ArticleIranian journal of microbiology2020

Clinical and microbial characterization of toxigenic

Sherein G Elgendy, Sherine A Aly, Rawhia Fathy, Enas A E Deaf, Naglaa H Abu Faddan, Muhamad R Abdel Hameed

Open access · diamondAbstract read
In one paragraph

Article in Iranian journal of microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Comparison of the LuminexJournal of medical microbiology · 2025
    Article
  3. Microorganisms · 2024
    Article
  4. Best Practices in the Management ofTropical medicine and infectious disease · 2024
    Review
  5. Article
  6. Antibiotic associated diarrhea due toIranian journal of microbiology · 2023
    Article
  7. Characteristics, Risk Factors, and Prevalence ofInfection and drug resistance · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sherein G ElgendyDepartment of Medical Microbiology and Immunology, School of Medicine, Assiut University, Assiut, Egypt.
Sherine A AlyDepartment of Medical Microbiology and Immunology, School of Medicine, Assiut University, Assiut, Egypt.
Rawhia FathyDepartment of Medical Microbiology and Immunology, School of Medicine, Assiut University, Assiut, Egypt.
Enas A E DeafDepartment of Medical Microbiology and Immunology, School of Medicine, Assiut University, Assiut, Egypt.
Naglaa H Abu FaddanDepartment of Pediatric Medicine, Assiut University Hospitals, Assiut University, Assiut, Egypt.
Muhamad R Abdel HameedDepartment of Internal Medicine, Hematology Unit, Assiut University Hospitals, Assiut University, Assiut, Egypt.
Assiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesMATERIALS AND

methodsStool samples were collected from 95 pediatric patients and 37 adult patients suffering from antibiotic associated diarrhea and were subjected to direct toxin immunoassay and culture on cycloserine/cefoxitin/fructose agar. The presence of

resultsToxigenic

conclusionDiabetes mellitus, prior antibiotic treatment, hematological malignancy on chemotherapy, malnutrition, neutropenia and Ryle feeding are risk factors for development of CDAD. Tight restriction of unnecessary antibiotic uses is necessary in our locality. Direct detection of toxin genes in stool by PCR is sensitive and specific method for early detection of

Indexed as

Clostridium difficileRisk factorToxigenic cultureToxin genes

Identifiers

PMID32994900
PMCPMC7502137
OpenAlexW3046714449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.